Allowing Medicare to cover anti-obesity medications would drive up federal spending by about $35 billion on net between 2026 and 2034, according to ...
A growing number of employers are considering covering the blockbuster weight-loss drugs, several surveys show. Workers will ...
The cost of taking weekly injections of popular anti-obesity medications liraglutide (Saxenda) or semaglutide (Wegovy) ...
A review of the recent evidence suggests that GLP-1 drugs, such as semaglutide, could protect brain health and cognitive ...
France is the latest European country to refuse to cover weight loss drugs through its national insurance programme.View on ...
Covering weight-loss drugs for elderly Americans on the state-backed Medicare health insurance programme would cost the US government $35bn over the next nine years, a congressional analysis has found ...
There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.
An obesity expert weighs in on intriguing new data and new drugs that hold promise in the battle against a stubborn problem.
Shares of WeightWatchers parent company WW International ($WW) have rocketed 40% higher on news that the company plans to ...
Shares of WeightWatchers parent company WW International (WW) have rocketed 40% higher on news that the company plans to sell obesity medications. Specifically, WeightWatchers is planning to sell ...
Popular weight loss drugs are so pricey that many may shell out hundreds or even thousands of dollars on them. Some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback